TriIs Incorporated
Notice on Monthly Exercise Status of the 17th Stock Acquisition Rights (with Exercise Price Adjustment Clause)
Regarding the stock acquisition rights (17th, with exercise price adjustment clause) for the target month, July exercises were 0 shares, and 80,800 shares remained unexercised. The number of outstanding issued shares at the end of the previous month was 9,030,000 shares, with 289,868 treasury shares.
Key Figures
- Outstanding issued shares: 9,030,000 shares
- Treasury shares: 289,868 shares
- Unexercised stock acquisition rights: 8,800 units
- Total stock acquisition rights: 18,100 units
AI要約
Disclosure status
This report notifies the monthly exercise status of the 17th stock acquisition rights (with exercise price adjustment clause) in July 2026, with 0 exercises and 0 shares issued during the target month. Total issued units were 18,100, and the monthly exercise ratio was 0.00%, at a low level. Unexercised stock acquisition rights at the end of the previous month and the end of the target month remain 8,800 units.
Impact on shareholders and outlook
This report discloses actual exercise results only and does not indicate any direct changes to dilution impact or capital policy. Going forward, exercise status of stock acquisition rights is expected to continue being disclosed, and impact on shareholders is anticipated to be limited.
TriEyes Co., Ltd.
Company overview · Stock price · Financial data · All IR
